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REVIEW OF ANIMAL EXPERIMENTATION IN INFECTIOUS
HEPATITIS AND IN SERUM HEPATITIS*
JAMES W. COLBERT, JR.t
Few diseases have sprung into prominence more quickly than have
the infectious hepatitides-infectious hepatitis and serum hepatitis. Both
British and American troops suffered heavily during the World War
years 1939-1945. During this period these diseases were assigned to the
category of virus diseases, and extensive investigations were carried out
in many laboratories in an attempt to isolate and define the properties
of the etiological agents which actually remain undefined. To date, man
is the only susceptible animal known to be infected by these agents. It
would seem, nevertheless, that the whole range of animals has not been
covered, and in an effort to plan future work in this field we have tried
to list here all of the experimental efforts, which we have been able to
find, either as recorded in the literature or as obtained from question-
naires. The data analyzed do not include all attempts to infect animals
with the virus of infectious or serum hepatitis, but they probably include
most of such attempts and have been collected with a view to providing
aready listof references so thatworkers may be able to see quickly what
techniques have been used with certain animals, what the source of the
infecting material has been, and what results have been obtained.
Methods
In reviewing the literature, the effort was made to analyze as much of the
available published material as possible, but it is obvious that we could not in.
clude all artides in whichonlybrief mention of attempts at experimental inocula-
tion of animals was made. However, it is probable that the majority of artides
containing such references, written in English, have been induded. Certain pre-
sumably significant experiments which have been recorded in the German litera-
ture have been reported, although an extensive survey of the German literature
was not made. All foreign-language literature is not recorded in this paper, al-
*This review was conducted in collaboration with the Commission on Virus and
Rickettsial Diseases, Army Epidemiological Board, Office of The Surgeon General, U. S.
Army, Washington, D. C., and forms part of a series of studies carried out in connection
with the work of the Hepatitis Research Center at the 120th Station Hospital, European
Command, U. S. Army, and at the Section of Preventive Medicine, Yale University School
of Medicine.
tNow at the Department of Internal Medicine, Yale University School of Medicine,
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though some of the German, Scandinavian, Dutch, Russian, and Spanish work
is represented.
To supplement the information obtained from published sources a series of
questionnaires was prepared and sent to a number of laboratories in this country.
Replies were received from the following: Dr. Charles Armstrong, National
Institutes of Health; Dr. S. Bayne-Jones, New York Hospital; Dr. George P.
Berry, University of Rochester; Dr. Paul F. Clark, University of Wisconsin; Dr.
Herald R. Cox, Lederle Laboratories; Dr. John H. Dingle, Western Reserve
School of Medicine; Dr. Monroe D. Eaton, Harvard University; Dr. C. A. Evans,
University of Washington; Dr. Thomas Francis, Jr., University of Michigan;
Dr. Donald T. Fraser, University of Toronto; Dr. W. F. Friedewald, Emory Uni-
versity; Dr. Francis B. Gordon, University of Chicago; Dr. W. P. Havens, Jr.,
Jefferson Medical College; Dr. Claus W. Jungeblut, Columbia University; Dr.
John F. Kessel, University of Southern California; Dr. Edwin C. Lennette, State
of California Department of Public Health; Dr. Perrin H. Long, Johns Hopkins
University; Dr. Colin M. MacLeod, New York University; Dr. Tracy B. Mallory,
Harvard University; Dr. Karl F. Meyer, University of California; Drs. P. K.
Olitsky and J. Casals, Rockefeller Institute for Medical Research; Dr. Leland W.
Parr, George Washington University, Washington, D. C.; Dr. Geoffrey W. Rake,
The Squibb Institute for Medical Research; Dr. T. M. Rivers, Hospital of the
Rockefeller Institute; Dr. A. B. Sabin, Children's Hospital Research Foundation,
Cincinnati; Dr. J. Stokes, Jr., University of Pennsylvania; Dr. Joseph E. Smadel,
Virus and Rickettsial Laboratory, U. S. ArmyMedical School, Washington, D. C.;
Dr. Jerome T. Syverton, Louisiana State University; Dr. Carl TenBroeck, Rocke-
feller Institute, Princeton, N. J.; Dr. Roy H. Turner, Tulane University; Dr.
Thomas B. Turner, Johns Hopkins University; Dr. C E. van Rooyen, University
of Toronto; Dr. C. J. Watson, University of Minnesota; Dr. Frederik B. Bang,
Johns Hopkins University; Dr. Joseph Lalich, University of Wisconsin.
Properties of the agents of infectious and serum hepatitis: Present-
day concepts of the agents causing infectious hepatitis (IH) and serum
hepatitis (SH) result from extensive investigations carried out during
the years of World War II. Such information has been obtained, for
the mostpart, from experimental disease produced in human volunteers.
Due to the obvious limitations of such methods it may be unwise to
make definitive statements concerning these agents, but a valuable
nucleus of facts has been established. It appears at the present time that
there is reason to believe that the virus of infectious hepatitis differs
from the virus of serum hepatitis, although they both belong apparently
to the same general group.21' 26, 41 For this reason the properties of these
agents, as they are known today, will be summarized separately.
Infectioushepatitis: Thefirstexperimental transmissionofthe agent
of infectious hepatitis was accomplished by Voegt in 1942 by feeding
infected duodenal fluid to a human volunteer.6" Since that time many
experiments, especially in England and in the United States, have beenINFECTIOUS AND SERUM HEPATITIS 337
TABLE 1
ANIMALS" USED IN EXPERIMENTAL ATTEPTS TO RECOVER THE VIRUSES OF INFECTIOUS HEPATITIS (IH) AND/OR SERUM HEPATITIS (SH) DURING THE PERIOD 1932-48
BIRDS
Chick embryos
Guinea-hen eggs
Canaries
Chickens
Ducks
Parakeets
Pheasants
Pigeons
Turkeys
MAMMALS
Cats
Dogs
Ferrets
Grasscutter (Thry-
onomys swinder-
ianus)
Guinea-pigs
Hamsters
Hedgehogs
Horses
Jerboas
Mice
Pigs
Porcupine (Atheu-
raafrKana)
Primates
Baboons
Unspecified
Abyssinian
Species used with wholly negative results Species with questionable results
(Rets.)
5,12,16,19,
39,51,53
16
31
16,39,51
16
3
16
12,56
16
8,11,12,16,
51,56,57
5,8,11,12,
51,56
11,12,16
14
11,12,14,16,
39,51,52,56,
57,61
5,39,51
11,12,14
5,6,33
57
5,10,11,12,
14,16,40,47,
51,56,57,61
1,2,6,11,12,
34,39,40,52,
56,57
14
39,56
57
MAMMALS, cont'd
P. anubis
choras
Chimpanzee
Monkeys
Unspecified
Cercopithecus
aethiops
C.a.sabeus
C. cephus
C. griseoviridis
C. mona mona
C. mona lowei
C. nctitans
petafisto
Cercocebus
torquatuis
Colobus badius
badiuss
Erythrocebus
tas
Lasiopyga gri-
seoviidsis
M. cynomolgus
M. rhesus
Rabbits
Rats
Unspecified
Cotton rats
Desert rats
White rats
TISSUE CULTURE
Rivers-Li & San-
ders ox serum
ultrfiltate
type
(Rets.)
14
28
5,16,34,56
12,57
14,40
40
58
40
14
14
14
14
14
57
40
10,11,12,40,
51,56
8,10,11,12,
14,16,39,51,
57,61
5,10,11,12,
14,34
16,51
56
40,51,57
35
BIRDS
Chick embryos
Canaries
MAMMALS
Ferrets
Guinea-pigs
Hamsters
Horses
Lambs
Mice
Pigs
Primates
Monkeys
Cercopithecus
aethiops
C. nictitans
petaurist
M. rhesus
Rabbits
Rats
Cotton rats
White rats
TISSUE CULTURE
Chick embryo
(Simms &
Sanders)
Rabbit liver
cells in roller
tubes
This table is a digest of a larger and more extensive table prepared by the author. For
reasons of economy, the larger table is not induded in this published report. A limited number
of photostat copies of the larger table are available for distribution with reprints of this article
if a special request is made.
carried out. The agent has been repeatedly demonstrated in the feces and
blood of patients in the acute phase of the disease (preicteric and early
icteric) 5, 15, 22, 28, 27, 29, 37, 42, 48, 44,45, 50 Experiments in which naso-
(Refs.)
16,48,53,54
7,30
51
5,10,32,40,
59
35
6
16
35
1,16,40
57
14
9
4
35
38,40
55
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pharyngeal washings or urine have been employed as the inocula in
human volunteers have been generally unsuccessful.23 87 43
Theperiod ofinfectivityofthe human diseasehasnotbeen definitely
established, but a small number ofexperiments has given some informa-
ation. The active stage of the disease is marked by the presence of the
agent in blood and feces. This agent was not demonstrable in the
blood on one occasion halfway through the incubation period, nor in
the stool or serum 26 days after the onset of disease,23 although it has
been demonstrated in the blood 3 days before the onset of symptoms."7
Attempts to recover the agent from feces in the convalescent phase 3
weeks after the disappearance of jaundice have been unsuccessful.45
With regard to the knownproperties of this agent, it has been found
that serum inoculated parenterally or orally, and feces administered
orally have successfully produced experimental disease in human volun-
teers with an incubation period falling between 10 and 40 days, with
an average time of 25 days.49 The method of preparation of the inocula
demonstrates that the agent is unusually thermostable withstanding
56°C. for 30 minutes.20 It can be passed through bacteria-tight filters.20
It is not destroyed in the presence of ether,37 and chlorination of water
with 1 part per million residual at 30 minutes does not attenuate the
virus."
Serum hepatitis: The etiologic agent of serum hepatitis differs in
some of its properties from the agent of infectious hepatitis. Attempts
to recover the agent from feces have been uniformly unsuccessful.24 5
Theonlyconsistentlypositive results have been obtained from blood and
blood products,36' 45, 46, 50 although nasopharyngeal washings produced
apositive result on oneoccasion.13
The period of infectivity differs markedly from that of infectious
hepatitis. The agent has been demonstrated in the blood both during the
long incubation period and the acute phase of illness, but it was absent
late in the disease in one experiment.24 The agent has been demonstrated
in serum 60 days before the onset of symptoms.50 Only the parenteral
route of inoculation has produced experimental disease with any con-
sistency and the results of these investigations reveal a prolonged in-
cubation time of from 60 to 150 days or more.49
The agent of serum hepatitis is also stable to heat and chemicals.
It withstands 56°C. for 1 hour, and the desiccated state for at least 14
months."5 It iscapable ofpassingbacteria-tightfilters.46 It survives in the
frozen state for years.26 Ultraviolet light for 1 hour at 2650 A and 1½V2
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hours at 2537 A destroys the infectivity* of the virus46 as does heating
to 60°C. for 10 hours.18
Summary of animal experimentation
The animal experimentation is summarized in the accompanying
table which is a digest of a more extensive table (cf. footnote to Table
1). The experiments are tabulated alphabetically by name of animal
species employed.
Discussion
It may be said that for all practical purposes no animal has yet
yielded satisfactory results. However, there have been a number of sug-
gestive experiments that merit comment. The work of Andersen and
Tulinius, in attempting toproduce thedisease inpigs,1 andthereportedly
successful chick embryo passage by Siede and Meding,54 and by Siede
and Luz,53 have been the most hopeful reports in the literature. A few
aspects of these investigations would, therefore, be worthy of brief
review.
A serious objection to the reported results of Andersen and Tulinius
has been the absence of confirmation by other workers whose attempts
to repeat the work are not inconsiderable. In the details of the original
experiments reported, it is noted that no clinical illness was observed in
the pigs and that the animals were sacrificed about four days after inocu-
lation. The lesions described in the livers of these animals were not
similar to those ofinfectious hepatitis in man. No necrosis was described
and no cellular infiltration was seen. The elevated plasma icterus would
seem convincing but one control animal also presented an elevated
icterus. The description of a spontaneous porcine hepatitis in Denmark
tends toobscure further the results of the experimentation.t
The passage of infectious hepatitis virus by inoculation of duodenal
fluid to chick embryos via the chorio-allantoic route by Siede and Med-
ing54 and by Siede and Luz53 has also not been consistently confirmed by
* A series of new experiments on the inactivation of hepatitis virus (SH) with
ultraviolet rays has recently been reported by Blanchard, Stokes, et al., J. Am. Med.
Asso., 1948, 138, 341.
tThe experiments of Andersen and Tulinius were of sufficient interest to the Virus
and Rickettsial Commission to warrant special investigation. For this purpose a visit
was paid in 1946 to Denmark by one of its members, Dr. W. P. Havens, Jr. From his
report it would seem that in Denmark two forms of hepatitis are recognized in swine:
(i) 'complicated' icterus in which jaundice is found associated with pyogenic infections
with multiple abscesses, pneumonia, or parasitic infestation; (ii) 'uncomplicated' icterus
in which no other apparent disease is associated. The livers of swine in the latter group
have areas of hemorrhagic necrosis and the disease is termed 'toxic liver dystrophy' and
is considered to be due to dietary deficiency of undetermined type. Both types are
uncommon.
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other workers. The criterion of successful passage in these experiments
was death of the embryo. No specific lesions in the embryo were
described, and the authors recognized the doubtful adequacy of their
criterion of stating a positive result. No attempt was made to infect
human volunteers with the chick embryo passage material.
The description of liver necrosis in inoculated {uinea-pigs by Mel-
nick et al.40 was considered at the time of experimentation to be incon-
sistent and more indicative of nonspecific lesions rather than related
specifically to the virus inoculated. However, the recent report by Ver-
linde59 of the consistent production of liver necrosis in guinea-pigs on
deficient diets and which had been inoculated with presumably in-
fectious (icterogenic) material may cause a different interpretation to
be given to these findings. But still more recently, Jersild and Krag32
were unable to confirm Verlinde's findings. However, they did find
that a small number of their injected guinea-pigs had fever and liver
changes in the form of an increase in Kupffer cells (without necrosis).
In a very small number of these, positive complement-fixation reactions
were demonstrable using liver suspensions as antigen, and sera from
animals which had been injected with material from cases of chronic
hepatitis as antibody.
Animal experimentation with these viruses has involved three
variables: (a) presence of the infecting agent; (b) an animal which is
susceptible; and (c) a means of recognizing the disease. Many of the
negative results cannot be definitely assigned to the lack of a susceptible
animal. For example, in reviewing the literature it appears that fre-
quently feces and duodenal contents from patients with serum
hepatitis were used. If the information gained from human volunteer
experiments is valid, then it is reasonable to assume that no virus was
present in the inocula. Criteria indicative of experimental disease in
animals may be difficult to discover. Clinical disease may never be
recognizable in any animal other than man. Certainly the absence of
observed illness in chimpanzees when inoculated with known infectious
material is disheartening.
Summary
A review of the major attempts to produce infectious hepatitis and
serum hepatitis in animals has been documented. No unequivocally
successful results have been found.
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